London
· Delayed Price · Currency is GBP · Price in USD Agios Pharmaceuticals Statistics
Total Valuation
LON:0HB0 has a market cap or net worth of GBP 1.60 billion. The enterprise value is 429.48 million.
| Market Cap | 1.60B |
| Enterprise Value | 429.48M |
Important Dates
The last earnings date was Thursday, February 13, 2025.
| Earnings Date | Feb 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +4.02% |
| Shares Change (QoQ) | -2.28% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 50.76M |
Valuation Ratios
The trailing PE ratio is 2.97.
| PE Ratio | 2.97 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 1.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.80 |
| EV / Sales | 14.88 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.37 |
Financial Position
The company has a current ratio of 11.90, with a Debt / Equity ratio of 0.04.
| Current Ratio | 11.90 |
| Quick Ratio | 11.06 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.15 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 57.29% and return on invested capital (ROIC) is -21.45%.
| Return on Equity (ROE) | 57.29% |
| Return on Assets (ROA) | -20.47% |
| Return on Invested Capital (ROIC) | -21.45% |
| Return on Capital Employed (ROCE) | -26.91% |
| Revenue Per Employee | 59,863 |
| Profits Per Employee | 1.11M |
| Employee Count | 488 |
| Asset Turnover | 0.03 |
| Inventory Turnover | 13.08 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +30.72% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +30.72% |
| 50-Day Moving Average | 35.25 |
| 200-Day Moving Average | 42.90 |
| Relative Strength Index (RSI) | 51.83 |
| Average Volume (20 Days) | 359 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.73 |
Income Statement
In the last 12 months, LON:0HB0 had revenue of GBP 29.15 million and earned 538.15 million in profits. Earnings per share was 9.30.
| Revenue | 29.15M |
| Gross Profit | -214.83M |
| Operating Income | -340.07M |
| Pretax Income | 573.49M |
| Net Income | 538.15M |
| EBITDA | -335.55M |
| EBIT | -340.07M |
| Earnings Per Share (EPS) | 9.30 |
Balance Sheet
The company has 713.87 million in cash and 45.52 million in debt, giving a net cash position of 1.18 billion.
| Cash & Cash Equivalents | 713.87M |
| Total Debt | 45.52M |
| Net Cash | 1.18B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.23B |
| Book Value Per Share | 21.54 |
| Working Capital | 706.47M |
Cash Flow
In the last 12 months, operating cash flow was -311.39 million and capital expenditures -1.35 million, giving a free cash flow of -312.74 million.
| Operating Cash Flow | -311.39M |
| Capital Expenditures | -1.35M |
| Free Cash Flow | -312.74M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -1,166.47% |
| Pretax Margin | 1,967.15% |
| Profit Margin | 1,845.92% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LON:0HB0 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.02% |
| Shareholder Yield | -4.02% |
| Earnings Yield | 33.71% |
| FCF Yield | -19.59% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LON:0HB0 has an Altman Z-Score of 10.54.
| Altman Z-Score | 10.54 |
| Piotroski F-Score | n/a |